Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Letters in Applied Microbiology
|
July 12, 2011
Behaviour of Listeria monocytogenes in packaged water buffalo mozzarella cheese
G Finazzi, P Daminelli, A Serraino, et al.
Leukemia
|
July 6, 2013
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis
T Barbui, A Carobbio, G Finazzi, et al.
Blood
|
December 9, 2000
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera
A Falanga, M Marchetti, V Evangelista, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 9, 1999
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study
P Bucciarelli, F R Rosendaal, A Tripodi, et al.
Thrombosis Research
|
May 11, 2016
PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN)
C Giaccherini, C Verzeroli, M Marchetti, et al.
Thrombosis and Haemostasis
|
June 1, 1994
Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S
V De Stefano, G Leone, S Mastrangelo, et al.
Thrombosis and Haemostasis
|
September 1, 1994
Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S
V De Stefano, G Leone, S Mastrangelo, et al.
Leukemia & Lymphoma
|
February 16, 2000
Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG
J J Michiels, T Barbui, G Finazzi, et al.
Leukemia
|
December 9, 2014
CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis
M C Finazzi, A Carobbio, F Cervantes, et al.
Blood Reviews
|
December 11, 2019
Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations
F Zaja, M Carpenedo, C Baratè, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Letters in Applied Microbiology
|
July 12, 2011
Behaviour of Listeria monocytogenes in packaged water buffalo mozzarella cheese
G Finazzi, P Daminelli, A Serraino, et al.
Leukemia
|
July 6, 2013
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis
T Barbui, A Carobbio, G Finazzi, et al.
Blood
|
December 9, 2000
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera
A Falanga, M Marchetti, V Evangelista, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 9, 1999
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study
P Bucciarelli, F R Rosendaal, A Tripodi, et al.
Thrombosis Research
|
May 11, 2016
PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN)
C Giaccherini, C Verzeroli, M Marchetti, et al.
Thrombosis and Haemostasis
|
June 1, 1994
Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S
V De Stefano, G Leone, S Mastrangelo, et al.
Thrombosis and Haemostasis
|
September 1, 1994
Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S
V De Stefano, G Leone, S Mastrangelo, et al.
Leukemia & Lymphoma
|
February 16, 2000
Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG
J J Michiels, T Barbui, G Finazzi, et al.
Leukemia
|
December 9, 2014
CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis
M C Finazzi, A Carobbio, F Cervantes, et al.
Blood Reviews
|
December 11, 2019
Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations
F Zaja, M Carpenedo, C Baratè, et al.
Page
of 14